Mortality related to invasive infections, sepsis, and septic shock in critically ill children in Australia and New Zealand, 2002-13: A multicentre retrospective cohort study

The Lancet Infectious Diseases

Volumn 15, Issue 1, 2015, Pages 46-54

  Schlapbach, Luregn J ^a,b,c   Straney, Lahn ^d   Alexander, Janet ^e   MacLaren, Graeme ^f,g,h   Festa, Marino ⁱ   Schibler, Andreas ^a   Slater, Anthony ^e  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b MATER CHILDREN S HOSPITAL   (Australia)

^c GOLD COAST UNIVERSITY HOSPITAL   (Australia)

^d MONASH UNIVERSITY   (Australia)

^e ROYAL CHILDREN'S HOSPITAL   (Australia)

^f ROYAL CHILDREN'S HOSPITAL   (Australia)

^g UNIVERSITY OF MELBOURNE   (Australia)

^h NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

ⁱ CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ARTICLE; AUSTRALIA AND NEW ZEALAND; BONE MARROW TRANSPLANTATION; CHILD; CHILDHOOD DISEASE; CHRONIC KIDNEY FAILURE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; ESCHERICHIA COLI; FEMALE; HAEMOPHILUS INFLUENZAE TYPE B; HOSPITAL ADMISSION; HUMAN; INCIDENCE; INFANT; INFECTION; INTENSIVE CARE; INTENSIVE CARE UNIT; KLEBSIELLA; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEISSERIA MENINGITIDIS; NEUROLOGIC DISEASE; NEWBORN; PSEUDOMONAS AERUGINOSA; REGISTER; RETROSPECTIVE STUDY; SEPSIS; SEPTIC SHOCK; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS GROUP A; STREPTOCOCCUS PNEUMONIAE; AUSTRALIA; CLINICAL TRIAL; CRITICAL ILLNESS; MULTICENTER STUDY; NEW ZEALAND; PRESCHOOL CHILD; SURVIVAL;

ADOLESCENT; AUSTRALIA; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; CRITICAL ILLNESS; FEMALE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; NEW ZEALAND; RETROSPECTIVE STUDIES; SEPSIS; SURVIVAL ANALYSIS;

EID: 84917705652     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(14)71003-5     Document Type: Article

References (33)

1. Dellinger RP, Levy MM, Carlet JM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008, 36:296-327.
2. Hotchkiss RS, Karl IE The pathophysiology and treatment of sepsis. N Engl J Med 2003, 348:138-150.
3. Liu L, Johnson HL, Cousens S, et al. Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000. Lancet 2012, 379:2151-2161.
4. Lozano R, Wang H, Foreman KJ, et al. Progress towards Millennium Development Goals 4 and 5 on maternal and child mortality: an updated systematic analysis. Lancet 2011, 378:1139-1165.
5. Watson RS, Carcillo JA, Linde-Zwirble WT, Clermont G, Lidicker J, Angus DC The epidemiology of severe sepsis in children in the United States. Am J Respir Crit Care Med 2003, 167:695-701.
6. Odetola FO, Gebremariam A, Freed GL Patient and hospital correlates of clinical outcomes and resource utilization in severe pediatric sepsis. Pediatrics 2007, 119:487-494.
7. Hartman ME, Linde-Zwirble WT, Angus DC, Watson RS Trends in the epidemiology of pediatric severe sepsis. Pediatr Crit Care Med 2013, 14:686-693.
8. For sepsis, the drugs don't work. Lancet Infect Dis 2012, 12:89. The Lancet Infectious Diseases.
9. Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003, 31:1250-1256.
10. Dellinger RP, Carlet JM, Masur H, et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 2004, 32:858-873.
11. de Oliveira CF, de Oliveira DS, Gottschald AF, et al. ACCM/PALS haemodynamic support guidelines for paediatric septic shock: an outcomes comparison with and without monitoring central venous oxygen saturation. Intensive Care Med 2008, 34:1065-1075.
12. Dellinger RP, Levy MM, Rhodes A, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 2013, 41:580-637.
13. Levy MM, Artigas A, Phillips GS, et al. Outcomes of the Surviving Sepsis Campaign in intensive care units in the USA and Europe: a prospective cohort study. Lancet Infect Dis 2012, 12:919-924.
14. Santiago CD, Menezes AM, de Carvalho WB, Delgado AF Epidemiologic challenges in sepsis to the developing countries. Pediatr Crit Care Med 2013, 14:336.
15. Ladhani SN, Flood JS, Ramsay ME, et al. Invasive meningococcal disease in England and Wales: implications for the introduction of new vaccines. Vaccine 2012, 30:3710-3716.
16. Laupland KB Incidence of bloodstream infection: a review of population-based studies. Clin Microbiol Infect 2013, 19:492-500.
17. Straney L, Clements A, Parslow RC, et al. Paediatric index of mortality 3: an updated model for predicting mortality in pediatric intensive care. Pediatr Crit Care Med 2013, 14:673-681.
18. Goldstein B, Giroir B, Randolph A International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med 2005, 6:2-8.
19. Slater A, Shann F, Pearson G PIM2: a revised version of the Paediatric Index of Mortality. Intensive Care Med 2003, 29:278-285.
20. Schlapbach LJ, Aebischer M, Adams M, et al. Impact of sepsis on neurodevelopmental outcome in a Swiss National Cohort of extremely premature infants. Pediatrics 2011, 128:e348-e357.
21. Kaukonen KM, Bailey M, Suzuki S, Pilcher D, Bellomo R Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000-2012. JAMA 2014, 311:1308-1316.
22. Rhee C, Gohil S, Klompas M Regulatory mandates for sepsis care-reasons for caution. N Engl J Med 2014, 370:1673-1676.
23. Jaramillo-Bustamante JC, Marin-Agudelo A, Fernandez-Laverde M, Bareno-Silva J Epidemiology of sepsis in pediatric intensive care units: first Colombian multicenter study. Pediatr Crit Care Med 2012, 13:501-508.
24. Ladhani S, Pebody RG, Ramsay ME, Lamagni TL, Johnson AP, Sharland M Continuing impact of infectious diseases on childhood deaths in England and Wales, 2003-2005. Pediatr Infect Dis J 2010, 29:310-313.
25. Lantto M, Renko M, Uhari M Changes in infectious disease mortality in children during the past three decades. Pediatr Infect Dis J 2013, 32:e355-e359.
26. Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001, 345:1368-1377.
27. Goal-directed resuscitation for patients with early septic shock. N Engl J Med 2014, 371:1496-1506. ARISE Investigators.
28. Yealy DM, Kellum JA, et al. A randomized trial of protocol-based care for early septic shock. N Engl J Med 2014, 370:1683-1693. ProCESS Investigators.
29. Zimmerman JE, Kramer AA, Knaus WA Changes in hospital mortality for United States intensive care unit admissions from 1988 to 2012. Crit Care 2013, 17:R81.
30. Wong HR Genetics and genomics in pediatric septic shock. Crit Care Med 2012, 40:1618-1626.
31. Wong HR, Cvijanovich NZ, Hall M, et al. Interleukin-27 is a novel candidate diagnostic biomarker for bacterial infection in critically ill children. Crit Care 2012, 16:R213.
32. Davila S, Wright VJ, Khor CC, et al. Genome-wide association study identifies variants in the CFH region associated with host susceptibility to meningococcal disease. Nature Genetics 2010, 42:772-776.
33. Thompson MJ, Ninis N, Perera R, et al. Clinical recognition of meningococcal disease in children and adolescents. Lancet 2006, 367:397-403.